Related Experiment Video
Updated: Jun 13, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Molecular testing in epidermolysis bullosa.
Daniele Castiglia1, Giovanna Zambruno
1Laboratory of Molecular and Cell Biology, IDI-IRCCS, Rome, Italy.
Dermatologic Clinics
|May 8, 2010
Summary
Advances in DNA technology allow genetic identification of epidermolysis bullosa (EB) genes. However, the genetic diversity of EB presents challenges for widespread molecular diagnostic testing.
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Significant advancements in DNA technology and human genome research have enabled the identification of genes causing epidermolysis bullosa (EB).
- This progress allows for precise determination of mutation locations and types in EB patients, facilitating gene-level diagnosis.
- However, the extensive genetic heterogeneity of EB complicates direct molecular testing for diagnosis.
Purpose of the Study:
- To review the most commonly employed molecular analysis methods for epidermolysis bullosa (EB).
Main Methods:
- The article reviews established and popular molecular techniques utilized in EB genetic analysis.
- Methods discussed likely include DNA sequencing, PCR-based analyses, and potentially array-based technologies.
Main Results:
- Identification of causative genes for various EB forms is now possible.
- Molecular diagnosis can pinpoint specific mutations at the gene level.
- Widespread molecular testing is hindered by EB's genetic heterogeneity and the limited availability of specialized laboratories.
Conclusions:
- While genetic advancements offer precise EB diagnosis, the disease's genetic complexity and resource limitations pose challenges for routine molecular testing.
- Further development and accessibility of molecular diagnostic tools are needed for broader EB patient care.
